Suppr超能文献

Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.

作者信息

Shaw P N, Houston J B, Rowland M, Hopkins K, Thiercelin J F, Morselli P L

出版信息

Br J Clin Pharmacol. 1985 Dec;20(6):611-8. doi: 10.1111/j.1365-2125.1985.tb05119.x.

Abstract

Antipyrine total clearance and the formation clearance of its major metabolites were studied in normal, healthy male volunteers before and after multiple dosing for approximately three weeks with phenytoin (six subjects) and carbamazepine (six subjects). Total antipyrine clearance increased on average by 91% after phenytoin dosing and by 61% after carbamazepine and individual increases correlated well with mean plasma concentrations of the anti-epileptic drug. The increase in total clearance resulted largely from increased formation clearances of the 4-hydroxy and 3-hydroxymethylantipyrine metabolites with minimal effect on the norantipyrine pathway, following treatment with both enzyme-inducing drugs. It is concluded that both phenytoin and carbamazepine have similar effects on antipyrine metabolism and that these effects are mediated by induction of specific forms of cytochrome P450.

摘要

相似文献

1
Antipyrine metabolite kinetics in healthy human volunteers during multiple dosing of phenytoin and carbamazepine.
Br J Clin Pharmacol. 1985 Dec;20(6):611-8. doi: 10.1111/j.1365-2125.1985.tb05119.x.
3
Differential effects of enzyme induction on antipyrine metabolite formation.
Br J Clin Pharmacol. 1982 Mar;13(3):379-86. doi: 10.1111/j.1365-2125.1982.tb01389.x.
4
Effect of phenytoin, carbamazepine, and valproic acid on caffeine metabolism.
Eur J Clin Pharmacol. 1989;36(4):401-6. doi: 10.1007/BF00558303.
5
The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
Br J Clin Pharmacol. 1985 Nov;20(5):469-74. doi: 10.1111/j.1365-2125.1985.tb05099.x.
7
The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
Br J Clin Pharmacol. 1987 Jul;24(1):51-5. doi: 10.1111/j.1365-2125.1987.tb03135.x.
8
Quinidine does not alter antipyrine metabolism.
J Clin Pharmacol. 1990 Mar;30(3):267-71. doi: 10.1002/j.1552-4604.1990.tb03471.x.
9
Interaction between metronidazole and drugs eliminated by oxidative metabolism.
Clin Pharmacol Ther. 1985 Apr;37(4):407-10. doi: 10.1038/clpt.1985.63.

引用本文的文献

1
Novel minimal physiologically-based model for the prediction of passive tubular reabsorption and renal excretion clearance.
Eur J Pharm Sci. 2016 Oct 30;94:59-71. doi: 10.1016/j.ejps.2016.03.018. Epub 2016 Mar 28.
2
Inhibition and induction of cytochrome P450 and the clinical implications.
Clin Pharmacokinet. 1998 Nov;35(5):361-90. doi: 10.2165/00003088-199835050-00003.
3
A comparative review of the adverse effects of anticonvulsants in children with epilepsy.
Drug Saf. 1996 Dec;15(6):378-93. doi: 10.2165/00002018-199615060-00003.
4
Clinically significant pharmacokinetic drug interactions with carbamazepine. An update.
Clin Pharmacokinet. 1996 Sep;31(3):198-214. doi: 10.2165/00003088-199631030-00004.
5
Antiepileptic drugs. A review of clinically significant drug interactions.
Drug Saf. 1993 Sep;9(3):156-84. doi: 10.2165/00002018-199309030-00003.
6
Induction and autoinduction properties of rifamycin derivatives: a review of animal and human studies.
Environ Health Perspect. 1994 Nov;102 Suppl 9(Suppl 9):101-5. doi: 10.1289/ehp.94102s9101.
7
Theophylline and antipyrine disposition in smoking and non-smoking epileptic subjects.
Br J Clin Pharmacol. 1987 Dec;24(6):812-5. doi: 10.1111/j.1365-2125.1987.tb03250.x.
8
Effect of the removal of individual antiepileptic drugs on antipyrine kinetics, in patients taking polytherapy.
Br J Clin Pharmacol. 1988 Sep;26(3):253-9. doi: 10.1111/j.1365-2125.1988.tb05274.x.
10
Pharmacokinetic drug interactions with phenytoin (Part II).
Clin Pharmacokinet. 1990 Feb;18(2):131-50. doi: 10.2165/00003088-199018020-00004.

本文引用的文献

1
The fate of antipyrine in man.
J Pharmacol Exp Ther. 1950 Jan;98(1):97-104.
2
Differential induction of antipyrine metabolism by rifampicin.
Eur J Clin Pharmacol. 1981;21(2):155-60. doi: 10.1007/BF00637517.
3
Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants.
Eur J Clin Pharmacol. 1982;22(5):441-5. doi: 10.1007/BF00542550.
5
Differential effects of enzyme induction on antipyrine metabolite formation.
Br J Clin Pharmacol. 1982 Mar;13(3):379-86. doi: 10.1111/j.1365-2125.1982.tb01389.x.
6
Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.
Br J Clin Pharmacol. 1983 Mar;15(3):317-21. doi: 10.1111/j.1365-2125.1983.tb01505.x.
8
Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.
Eur J Clin Pharmacol. 1983;25(2):215-22. doi: 10.1007/BF00543794.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验